JPRN-UMIN000029975已完成未知
Effect of SGLT2 inhibitor (Lusefi) on diabetic nephropathy Stratified analysis based on different original renal function category - CHAT-Lu
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 53
研究概览
简要总结
There was no significant decrease in eGFR over 2 years, demonstrating renoprotective effects of luseogliflozin in patients with type 2 diabetes. Changes in eGFR were not correlated with changes in HbA1c. On the other hand, luseogliflozin had lesser renal protective effect in patients with overt proteinuria. In this study, blood sugar lowering effect, blood pressure lowering effect, liver function improving effect, and weight loss effect were also observed.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •past use of SGLT2 inhibitor severe ketoacidosis,diabetes coma,type1diabetes severe infection,pre and post operation,severe in injury pregnancy,lactation,potential pregnancy
研究者
相似试验
已完成
不适用
ong-term renoprotective effect of SGLT2 inhibitorstype 2 diabetes melllitusJPRN-UMIN000034387ephrology Division, JA Toride Medical Center60
已完成
3 期
Evaluation Renoprotective Effect SGLT2 inhibitors on Prognosis of Transplant Kidney PatientsCondition 1: Diabetes mellitus type 2. Condition 2: Transplant Kidney.Type 2 diabetes mellitus with kidney complicationsKidney transplant statusE11.2Z94.0IRCT20220708055414N1Orchidpharmed30
已完成
不适用
A prospective observational study in type 2 diabetic patients showing reduced eGFR without albuminuriaJPRN-UMIN000038835Edogawa Hospital Department of Diabetes, Metabolism and Kidney Disease675
已完成
不适用
The Effect of SGLT2 inhibitors on blood glucose variability in patients with type 1 diabetestype 1 diabetes mellitusJPRN-UMIN000039361Hokkaido University Hospital30
招募中
不适用
Effects of a SGLT2 Inhibitor in type 2 Diabetes Mellitustype 2 Diabetes MellitusJPRN-UMIN000017461ephrology, endocrinology and vascular medicine at Tohoku University Hospital60